s6y Telomir Pharmaceuticals, Inc. EFFECT

Telomir Pharmaceuticals, Inc. EFFECT, filed Nov 5, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 5, 2026 4:00 P.M.
Form: S-3
CIK: 0001971532
Company Name: Telomir Pharmaceuticals, Inc.
File Number: 333-299654